UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus

The New England journal of medicine, 2014-04, Vol.370 (14), p.1316-1326

2014

Volltextzugriff (PDF)

Vaccine Prevention of Maternal Cytomegalovirus Infection

The New England journal of medicine, 2009-03, Vol.360 (12), p.1191-1199

2009

Volltextzugriff (PDF)

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

American journal of transplantation, 2010-05, Vol.10 (5), p.1228-1237

2010

Volltextzugriff (PDF)

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2013-09, Vol.369 (13), p.1227-1236

2013

Volltextzugriff (PDF)

High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

The Journal of infectious diseases, 2014-02, Vol.209 (4), p.557-561

2014

Volltextzugriff (PDF)

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

The New England journal of medicine, 2005-09, Vol.353 (13), p.1350-1362

2005

Volltextzugriff (PDF)

Pretransplant Immediately Early‐1‐Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation

American journal of transplantation, 2013-07, Vol.13 (7), p.1793-1805

2013

Volltextzugriff (PDF)

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American journal of transplantation, 2007-09, Vol.7 (9), p.2106-2113

2007

Volltextzugriff (PDF)

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

The Lancet infectious diseases, 2011-04, Vol.11 (4), p.284-292

2011

Volltextzugriff (PDF)

Congenital cytomegalovirus (CMV) epidemiology and awareness

Journal of clinical virology, 2009-12, Vol.46, p.S6-S10

Cannon, Michael J

2009

Volltextzugriff (PDF)

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

Clinical infectious diseases, 2008-03, Vol.46 (6), p.840-846

2008

Volltextzugriff (PDF)

Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital

Journal of clinical virology, 2009-12, Vol.46, p.S49-S53

2009

Volltextzugriff (PDF)

Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients

Clinical infectious diseases, 2014-12, Vol.59 (11), p.1537-1545

2014

Volltextzugriff (PDF)

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial

Annals of internal medicine, 2010-06, Vol.152 (12), p.761

2010

Volltextzugriff (PDF)

Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial

Transplantation, 2012-01, Vol.93 (1), p.61-68

2012

Volltextzugriff (PDF)

Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American journal of transplantation, 2013-09, Vol.13 (9), p.2402-2410

2013

Volltextzugriff (PDF)

Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid‐Organ Transplantation

American journal of transplantation, 2011-11, Vol.11 (11), p.2463-2471

2011

Volltextzugriff (PDF)

Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis

Journal of perinatal medicine, 2012-06, Vol.40 (4), p.439-446

2012

Volltextzugriff (PDF)

Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors

Transfusion (Philadelphia, Pa.), 2013-10, Vol.53 (10), p.2190-2197

2013

Volltextzugriff (PDF)

Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis

Transplantation, 2006-06, Vol.81 (12), p.1645-1652

2006

Volltextzugriff (PDF)

Evaluation of Cytomegalovirus (CMV)-Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV-Specific T Cell Reconstitution in Kidney Transplant Recipients

The Journal of infectious diseases, 2010-08, Vol.202 (4), p.585-594

2010

Volltextzugriff (PDF)

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Blood, 2011-11, Vol.118 (20), p.5689-5696

2011

Volltextzugriff (PDF)

Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant

The Journal of infectious diseases, 2012-04, Vol.205 (8), p.1294-1304

2012

Volltextzugriff (PDF)

Maternal immunity and prevention of congenital cytomegalovirus infection

JAMA : the journal of the American Medical Association, 2003-02, Vol.289 (8), p.1008

2003

Volltextzugriff (PDF)

1 – 25 von 597

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTransplantation Proceedings

ThemaFemale

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(578)
Mit Volltextzugriff
(410)

Publikationsform

Artikel
(597)

Sprache

Englisch
(597)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(597)
Humans
(576)
Science & Technology
(551)
Life Sciences & Biomedicine
(550)
Male
(501)
Cytomegalovirus Infections - Prevention & Control
(443)
Adult
(436)
Middle Aged
(378)
Cytomegalovirus
(332)
Transplantation
(279)
Adolescent
(233)
Immunology
(229)
Infectious Diseases
(225)
Pharmacology. Drug Treatments
(174)
Antiviral Agents - Therapeutic Use
(172)
Viral Diseases
(167)
Surgery
(166)
Ganciclovir - Therapeutic Use
(165)

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(597)
Journals@Ovid Full Text
(448)
EZB Electronic Journals Library
(293)
Ingenta
(192)
NUS Single-Journal Subscriptions
(169)
Wiley Online Library Journals
(105)
Wiley Online Library
(98)
Elsevier ScienceDirect Journals Complete
(87)
Nexis Uni
(75)
Nature
(75)
Oxford Journals
(68)
Oxford Journals 2020 Medicine
(68)
IngentaConnect Journals
(65)
JSTOR
(62)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(53)
Springer journals
(23)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(20)
Taylor & Francis Online
(8)
Taylor & Francis Journals
(8)
Taylor & Francis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus

Vaccine Prevention of Maternal Cytomegalovirus Infection

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

Pretransplant Immediately Early‐1‐Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

Congenital cytomegalovirus (CMV) epidemiology and awareness

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital

Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial

Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial

Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid‐Organ Transplantation

Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis

Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors

Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis

Evaluation of Cytomegalovirus (CMV)-Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV-Specific T Cell Reconstitution in Kidney Transplant Recipients

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant

Maternal immunity and prevention of congenital cytomegalovirus infection

Aktive Filter

Suchergebnisse filtern